DeepMed Research

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Myocardial Perfusion and Scarring in Congenital Heart Disease

Terminated

Conditions: Congenital Heart Disease

First Posted Date: 2012-07-13

Last Posted Date: 2021-12-02

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 18

Registration Number: NCT01639937

Locations: 🇺🇸
Childrens National Medical Center, Washington, District of Columbia, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Suburban Hospital, Bethesda, Maryland, United States

Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications

Phase 1

Completed

Conditions: Graft-Versus-Host Disease

First Posted Date: 2012-07-04

Last Posted Date: 2019-12-12

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 10

Registration Number: NCT01633229

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Heart Imaging in Children With Muscular Dystrophy

Terminated

Conditions: Muscular Dystrophy

First Posted Date: 2012-07-04

Last Posted Date: 2019-09-13

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 2

Registration Number: NCT01633242

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Neutropenia
Acute Myeloid Leukemia (AML)
Myeldysplastic Syndrome (MDS)
Chronic Myelomonocytic Leukemia
Bone Marrow Diseases

First Posted Date: 2012-06-27

Last Posted Date: 2019-12-17

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 4

Registration Number: NCT01629082

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Phase 1

Active, not recruiting

Conditions: Severe Aplastic Anemia

Interventions: Drug: Extension Cohort

First Posted Date: 2012-06-19

Last Posted Date: 2025-03-11

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 207

Registration Number: NCT01623167

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluating New Radiation Techniques for Cardiovascular Imaging

Not Applicable

Recruiting

Conditions: Coronary Disease

Interventions: Device: Cannon Aquilion ONE CT system

First Posted Date: 2012-06-18

Last Posted Date: 2025-05-22

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 5000

Registration Number: NCT01621594

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Microvessels and Heart Problems in Sickle Cell Disease

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2012-05-21

Last Posted Date: 2017-10-27

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 65

Registration Number: NCT01602809

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)

Phase 2

Completed

Conditions: Arterial Calcification
CD73 Deficiency

Interventions: Drug: Etidronate
Device: MRI Scan

First Posted Date: 2012-04-25

Last Posted Date: 2022-10-04

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 7

Registration Number: NCT01585402

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease

Phase 1

Withdrawn

Conditions: Pulmonary Hypertension

First Posted Date: 2012-04-02

Last Posted Date: 2018-07-05

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT01568645

Blood Flow and Pain Crises in People With Sickle Cell Disease

Completed

Conditions: Sickle Cell Disease

First Posted Date: 2012-04-02

Last Posted Date: 2018-10-09

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 94

Registration Number: NCT01568710

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy